NOVA (CRYPTO: SN68) — Company Overview, News & Financial Data
NOVA is a decentralized AI drug discovery network operating as Subnet 68 on the Bittensor ecosystem, developed by Metanova Labs.
NOVA
About
NOVA is a decentralized AI drug discovery network operating as Subnet 68 on the Bittensor ecosystem, developed by Metanova Labs. The protocol leverages crowdsourced machine learning models and open competitive benchmarks to accelerate early-stage drug design and molecular optimization. Machine learning miners compete to generate and evaluate candidate therapeutics, while validators verify prediction accuracy and score model performance. By incentivizing global research contributors through tokenized rewards, NOVA creates an open framework for computational chemistry, targeted molecular docking, and AI-driven agency therapeutics to streamline pharmaceutical development.
Snapshot
Operations
Products and/or services of NOVA
- Decentralized Drug Discovery Network: Distributed computational infrastructure operating on Subnet 68 that runs open chemistry benchmarks, rewarding artificial intelligence miners for predicting molecular binding affinities and optimizing lead compound structures for pharmaceutical targets.
- AI Miner Model Competitions: Continuous open machine learning challenges where independent algorithm developers deploy generative AI and computational chemistry models to solve targeted molecular design problems and maximize binding efficacy scores.
- Validator Evaluation Infrastructure: Verification consensus system where network validators evaluate miner submissions against biological datasets, score prediction accuracy metrics, and distribute protocol emissions across active subnet nodes on the blockchain.
- Agency Therapeutics Engine: Automated computational pipeline integrating machine learning compound generation with virtual screening workflows to accelerate early-stage drug design, lead optimization, and bioactivity profiling for targeted therapeutic discovery.
- Subnet Token Reward Mechanism: Incentive architecture operating on the underlying Bittensor consensus protocol that allocates daily cryptocurrency emissions to miners and validators based on validated performance in molecular property prediction tasks.
- Open Benchmark Datasets: Standardized repository of chemical compound libraries, structural biology profiles, and bioactivity target benchmarks utilized for training neural networks and evaluating virtual screening algorithms across the decentralized research ecosystem.